These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 7674250)

  • 21. Long-term treatment with methotrexate or tumor necrosis factor alpha inhibitors does not increase epstein-barr virus load in patients with rheumatoid arthritis.
    Balandraud N; Guis S; Meynard JB; Auger I; Roudier J; Roudier C
    Arthritis Rheum; 2007 Jun; 57(5):762-7. PubMed ID: 17530675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis presenting in the skin.
    Clarke LE; Junkins-Hopkins J; Seykora JT; Adler DJ; Elenitsas R
    J Am Acad Dermatol; 2007 Apr; 56(4):686-90. PubMed ID: 17141365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
    Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
    Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate-related lymphoproliferative disorder with extensive vascular involvement in a patient with rheumatoid arthritis.
    Shimura C; Satoh T; Takayama K; Yokozeki H
    J Am Acad Dermatol; 2009 Jul; 61(1):126-9. PubMed ID: 19539849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate.
    Padeh S; Sharon N; Schiby G; Rechavi G; Passwell JH
    J Rheumatol; 1997 Oct; 24(10):2035-7. PubMed ID: 9330950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
    Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
    Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
    Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
    Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
    Hatachi S; Kunitomi A; Aozasa K; Yagita M
    Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-related MTX-LPD in rheumatoid arthritis patients exhibits a viral pattern of the CD64 and CD35 expression on neutrophils: three case reports.
    Mokuda S; Miyazaki T; Saeki Y; Masumoto J; Kanno M; Takasugi K
    Mod Rheumatol; 2015 Jan; 25(1):166-8. PubMed ID: 24499448
    [No Abstract]   [Full Text] [Related]  

  • 31. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases.
    Kojima M; Itoh H; Hirabayashi K; Igarashi S; Tamaki Y; Murayama K; Ogura H; Saitoh R; Kashiwabara K; Takimoto J; Masawa N; Nakamura S
    Pathol Res Pract; 2006; 202(9):679-85. PubMed ID: 16859835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
    Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
    J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
    He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
    Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment.
    Koji H; Yazawa T; Nakabayashi K; Fujioka Y; Kamma H; Yamada A
    Mod Rheumatol; 2016; 26(2):271-5. PubMed ID: 24386983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EBV-associated diffuse large B-cell lymphoma in a psoriatic treated with methotrexate.
    Hsiao SC; Ichinohasama R; Lin SH; Liao YL; Chang ST; Cho CY; Chuang SS
    Pathol Res Pract; 2009; 205(1):43-9. PubMed ID: 18951733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
    Kojima M; Motoori T; Nakamura S
    Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
    Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
    Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency.
    Hamilton-Dutoit SJ; Rea D; Raphael M; Sandvej K; Delecluse HJ; Gisselbrecht C; Marelle L; van Krieken HJ; Pallesen G
    Am J Pathol; 1993 Oct; 143(4):1072-85. PubMed ID: 8214003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphoma in a patient with rheumatoid arthritis receiving methotrexate treatment: successful treatment with rituximab.
    Stewart M; Malkovska V; Krishnan J; Lessin L; Barth W
    Ann Rheum Dis; 2001 Sep; 60(9):892-3. PubMed ID: 11502618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.